Cian Healthcare 23rd AGM: All 6 resolutions passed including ESOP 2026 approval
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Cian Healthcare held its 23rd AGM on September 29, 2026 via video conferencing. All 6 resolutions were passed with 100 percent votes in favour (76.27 percent polling). Key items: adoption of FY26 audited financials, re-appointment of Pradeep Kumar Jain as Non-Executive Director, appointment of M/s Rasool Singhal & Co as Statutory Auditors, and approval of Employee Stock Option Scheme 2026 covering employees of group/subsidiary/associate companies. Chairman also briefed members on the company performance and the Corporate Insolvency Resolution Process it underwent.
ESOP 2026 approval may lead to equity dilution over time. All routine items passed with full majority show shareholder support.